Last edition
News about "Red Herring Prospectus"
Symbiotec Pharmalab to Open IPO for Subscription on August 24, 2026
Symbiotec Pharmalab will open its IPO for subscription from August 24–27, 2026, with a price band of INR 938–INR 988 per share and an OFS component of up to INR 1,607 crore.
Red Herring Prospectus | 20/08/2026 | By News Bureau | 109
Senores Pharmaceuticals to Acquire Two ANDAs from Teva in USD 120 Million Market Opportunity
Senores Pharmaceuticals (SPL), through its wholly-owned US subsidiary Senores Pharmaceuticals, USA (SPI), has signed an agreement to acquire two USFDA-approved Abbreviated New Drug Applications (ANDAs) from Teva Pharmaceuticals USA.
Red Herring Prospectus | 13/08/2025 | By Darshana | 220
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy